ISA Pharmaceuticals
Developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€104—156m (Dealroom.co estimates Jul 2021.)
Company register number 34215632
Leiden South Holland (HQ)
Authorizing premium user...